Alam Md Shahid, Mistry Suraj, Das Sudipta, Mukherjee Suchetna, Kumar Amitabh, Rao Girish Shiva
Aditya Birla Sankara Nethralaya, Kolkata, West Bengal, India.
A Unit of Medical Research Foundation, Chennai, Tamil Nadu, India.
Oman J Ophthalmol. 2021 Oct 20;14(3):162-168. doi: 10.4103/ojo.ojo_61_21. eCollection 2021 Sep-Dec.
To describe, the impact of ongoing coronavirus disease 2019 (COVID-19) pandemic on ophthalmic surgeries at a tertiary eye care center of East India during and after the lockdown, and the positivity rate for novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]).
A retrospective study of all ophthalmic surgeries performed during and after lockdown from April 1, 2020 to August 31, 2020, with comparison to the corresponding period in the previous year (2019) was done. Eligible patients were tested for novel coronavirus (SARS-CoV-2) preoperatively as per the institutional protocols.
A total of 569 surgeries were performed during the study period compared to 3458 performed in 2019, ( = 0.00001). The maximum number of surgeries were performed in June (191, 33.57%) and July (189, 33.22%) and in the subspecialty of vitreo-retina (337, 59.23%) followed by cataract (101, 17.75%). The most common vitreoretinal procedures were intravitreal injections (223, 66.17%) and retinal detachment surgery (56, 16.62%). Emergency surgeries performed were 30 (5.275%) compared to 76 (2.20%) during the same duration in the previous year ( = 0.00004). Ninety-four (16.52%) cases were screened for COVID-19. A total of 10 (10.64%) cases tested positive for SARS-CoV-2. Only one of these cases was symptomatic.
There was a drastic decline in the number of both elective and emergency surgeries during and after the lockdown period of the COVID-19 pandemic when compared to the corresponding previous year duration. The maximum number of surgeries was performed in the vitreoretinal subspecialty. The positivity rate for SARS CoV-2 amongst the patients tested was 10.64% and most of these patients were asymptomatic.
描述2019年冠状病毒病(COVID-19)大流行在印度东部一家三级眼科护理中心封锁期间及之后对眼科手术的影响,以及新型冠状病毒(严重急性呼吸综合征冠状病毒2 [SARS-CoV-2])的阳性率。
对2020年4月1日至2020年8月31日封锁期间及之后进行的所有眼科手术进行回顾性研究,并与上一年(2019年)同期进行比较。符合条件的患者按照机构方案在术前进行新型冠状病毒(SARS-CoV-2)检测。
研究期间共进行了569例手术,而2019年为3458例(P = 0.00001)。手术数量最多的月份是6月(191例,33.57%)和7月(189例,33.22%),在玻璃体视网膜亚专业进行的手术最多(337例,59.23%),其次是白内障手术(101例,17.75%)。最常见的玻璃体视网膜手术是玻璃体内注射(223例,66.17%)和视网膜脱离手术(56例,16.62%)。紧急手术为30例(5.275%),而上一年同期为76例(2.20%)(P = 0.00004)。94例(16.52%)病例接受了COVID-19筛查。共有10例(10.64%)病例SARS-CoV-2检测呈阳性。这些病例中只有1例有症状。
与上一年同期相比,COVID-19大流行封锁期间及之后,择期手术和紧急手术的数量均大幅下降。手术数量最多的是玻璃体视网膜亚专业。接受检测的患者中SARS-CoV-2的阳性率为10.64%,且这些患者大多无症状。